Talis Biomedical Corp reports results for the quarter ended in June - Earnings Summary

Talis Biomedical

11/08/2021 24:47

* Talis Biomedical Corp  TLIS.OQ  reported a quarterly adjusted
loss of $2.51​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 91 cents per share.
* Revenue was $117.00 thousand​;  analysts expected zero. 
* Talis Biomedical Corp's reported EPS for the quarter was a
loss of $2.51​.
* The mean earnings estimate of analysts had fallen by
about 32.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Talis Biomedical Corp shares had fallen by 12.3% this quarter.
* The company reported a quarterly loss of $64.47 million.
* Wall Street's median 12-month price target for Talis
Biomedical Corp is $13.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 11:47 p.m.  ​All
figures in US dollars unless otherwise stated